Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical Trials.

American journal of respiratory and critical care medicine·2026

Same author

A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians.

Journal of clinical medicine·2026

Same author

Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials.

American journal of respiratory and critical care medicine·2026

Same author

Lungs and heart in COPD exacerbations: it takes two to tango.

European journal of internal medicine·2026

Same author

Body Mass Index-related genetic factors and COPD imaging phenotypes.

Annals of the American Thoracic Society·2026

Same author

Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium Scores.

Chest·2025

Search research articles

Related Experiment Videos

Predictors of mortality in COPD.

Bartolome R Celli¹

¹Tufts University, St. Elizabeth's Medical Center, 736 Cambridge St., Boston, MA 02135, USA. bcelli@copdnet.org

Respiratory Medicine

|April 27, 2010

Summary

For Chronic Obstructive Pulmonary Disease (COPD), clinical factors like dyspnea and exercise capacity better predict mortality than FEV(1) alone. The BODE index integrates these factors for improved survival prediction in COPD patients.

Area of Science:

Pulmonary Medicine
Clinical Epidemiology

Background:

Chronic Obstructive Pulmonary Disease (COPD) significantly contributes to adult morbidity and mortality.
FEV(1) is a key indicator of airflow obstruction severity in COPD, but its mortality predictive value diminishes when above 50% of predicted.
Clinical variables beyond FEV(1) demonstrate stronger predictive capabilities for mortality across a spectrum of COPD airflow limitation.

Purpose of the Study:

To review established and emerging predictors of mortality in COPD patients.
To highlight the limitations of FEV(1) as a sole predictor of COPD mortality.
To introduce the BODE index as a comprehensive tool for assessing COPD severity and survival.

Main Methods:

Review of existing literature on COPD mortality predictors.

Related Experiment Videos

Analysis of clinical variables including functional dyspnea, exercise capacity, and Body Mass Index (BMI).

Evaluation of the BODE index (BMI, airflow Obstruction, Dyspnea, Exercise capacity) as a multidimensional predictor.

Main Results:

Functional dyspnea, exercise capacity, and BMI are significant predictors of mortality in COPD.
The BODE index effectively integrates these clinical variables, offering superior predictive validity compared to FEV(1) alone.
Biomarker profiles are emerging as potential future predictors of COPD outcomes.

Conclusions:

Clinical factors provide more robust mortality prediction in COPD than FEV(1) in many cases.
The BODE index serves as a validated, single surrogate measure for disease severity and survival in COPD.
Further research into biomarker profiles may enhance future COPD outcome predictions.